跳至主要内容
临床试验/NL-OMON54493
NL-OMON54493招募中不适用

Early diagnostic BioMARKers in Exacerbations of COPD: the MARKED study - the MARKED study

Ciro0 个研究点目标入组 162 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
162

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • COPD patients:
  • In order to be eligible to participate in this study, a patient must meet all
  • of the following criteria:
  • - >= 40 years old
  • - >= 10 packyears of smoking
  • - primary diagnosis of COPD and post-bronchodilator ratio of forced expiratory
  • volume in the first second (FEV1) to forced vital capacity (FVC) of less than
  • - clinical indication for inpatient pulmonary rehabilitation in CIRO
  • - provided written informed consent

排除标准

  • A potential COPD patient who meets any of the following criteria will be
  • excluded from participation in this study:
  • - current diagnosis of asthma
  • - unstable concurrent cardiovascular, metabolic, renal, gastro-intestinal and
  • musculoskeletal chronic diseases (as judged by the investigator)
  • - chronic use of oral corticosteroids >10 mg prednisolone/day
  • - initiation of maintenance therapy with macrolides < 6 weeks prior to study
  • - anemia, defined as hemoglobin level < 8.1 mmol/L in men and < 7.5 mmol/L in
  • - participation in a study involving investigational or marketed products
  • concomitantly or < 8 weeks prior to study entry
  • - unable to read, speak or understand Dutch

研究者

发起方
Ciro

相似试验

Early diagnostic BioMARKers in Exacerbations of... | 临床试验